128 related articles for article (PubMed ID: 37932055)
1. Diagnosis of thanatophoric dysplasia using clinical exome screening.
Holub M; Sekowská M; Smetanová D; Koudová M; Sobolová K; Šinská A; Heřman H
Ceska Gynekol; 2023; 88(5):376-379. PubMed ID: 37932055
[TBL] [Abstract][Full Text] [Related]
2. Thanatophoric dysplasia: a case report.
Jagun OE; Olusola-Bello MA; Adekanmbi AF; Jagun OO; Oduwole T
Pan Afr Med J; 2020; 37():220. PubMed ID: 33520059
[TBL] [Abstract][Full Text] [Related]
3. Increased first-trimester nuchal translucency associated with thanatophoric dysplasia type 1.
Zhen L; Pan M; Han J; Yang X; Liao C; Li DZ
J Obstet Gynaecol; 2015; 35(7):685-7. PubMed ID: 25671245
[TBL] [Abstract][Full Text] [Related]
4. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
Terasawa S; Kato A; Nishizawa H; Kato T; Yoshizawa H; Noda Y; Miyazaki J; Ito M; Sekiya T; Fujii T; Kurahashi H
Congenit Anom (Kyoto); 2019 Jan; 59(1):4-10. PubMed ID: 29542187
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of thanatophoric dysplasia in the second trimester: ultrasonography and other diagnostic modalities.
Sahinoglu Z; Uludogan M; Gurbuz A; Karateke A
Arch Gynecol Obstet; 2003 Nov; 269(1):57-61. PubMed ID: 14605823
[TBL] [Abstract][Full Text] [Related]
6. First-trimester molecular prenatal diagnosis of a thanatophoric dysplasia.
Delahaye S; Rosenblatt J; Costa JM; Bazin A; Bénifla JL; Jouannic JM
Prenat Diagn; 2010 Dec; 30(12-13):1222-3. PubMed ID: 20949643
[No Abstract] [Full Text] [Related]
7. Second trimester molecular diagnosis of a stop codon FGFR3 mutation in a type I thanatophoric dysplasia fetus following abnormal ultrasound findings.
Chen CP; Chern SR; Chang TY; Lin CJ; Wang W; Tzen CY
Prenat Diagn; 2002 Aug; 22(8):736-7. PubMed ID: 12210587
[No Abstract] [Full Text] [Related]
8. Thanatophoric dysplasia type I associated with increased nuchal translucency in the first trimester: Early prenatal diagnosis using combined ultrasonography and molecular biology.
Tonni G; Azzoni D; Ventura A; Ferrari B; Felice CD; Baldi M
Fetal Pediatr Pathol; 2010; 29(5):314-22. PubMed ID: 20704477
[TBL] [Abstract][Full Text] [Related]
9. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation.
De Biasio P; Prefumo F; Baffico M; Baldi M; Priolo M; Lerone M; Tomà P; Venturini PL
Prenat Diagn; 2000 Oct; 20(10):835-7. PubMed ID: 11038465
[TBL] [Abstract][Full Text] [Related]
10. Perinatal imaging findings and molecular genetic analysis of thanatophoric dysplasia type 1 in a fetus with a c.2419T>G (p.Ter807Gly) (X807G) mutation in FGFR3.
Chen SW; Chen CP; Wang LK; Chern SR; Wu PC; Chen YN; Lin CJ; Chen WL; Wang W
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):87-92. PubMed ID: 28254233
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of common mutations of the FGFR3 gene causing thanatophoric dysplasia type I: two case reports.
Yang Y; Liu YN; Li DZ
Fetal Pediatr Pathol; 2012 Jun; 31(3):128-33. PubMed ID: 22414243
[TBL] [Abstract][Full Text] [Related]
12. Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update.
Lemyre E; Azouz EM; Teebi AS; Glanc P; Chen MF
Can Assoc Radiol J; 1999 Jun; 50(3):185-97. PubMed ID: 10405653
[TBL] [Abstract][Full Text] [Related]
13. [Prenatal diagnosis of thanatophoric dysplasia at 21st week of pregnancy].
Camera G; Dodero D; Camandona F; Camera A
Pathologica; 1993; 85(1096):215-9. PubMed ID: 8361784
[TBL] [Abstract][Full Text] [Related]
14. A case of thanatophoric dysplasia: the early prenatal 2D and 3D sonographic findings and molecular confirmation of diagnosis.
Wong HS; Kidd A; Zuccollo J; Tuohy J; Strand L; Tait J; Pringle KC
Fetal Diagn Ther; 2008; 24(1):71-3. PubMed ID: 18504386
[TBL] [Abstract][Full Text] [Related]
15. Second-trimester molecular diagnosis of a heterozygous 742 --> T (R248C) mutation in the FGFR3 gene in a thanatophoric dysplasia variant following suspicious ultrasound findings.
Chen CP; Chern SR; Wang W; Wang TY
Ultrasound Obstet Gynecol; 2001 Mar; 17(3):272-3. PubMed ID: 11309183
[No Abstract] [Full Text] [Related]
16. Identification of a novel insertion mutation in FGFR3 that causes thanatophoric dysplasia type 1.
Lindy AS; Basehore MJ; Munisha M; Williams AL; Friez MJ; Writzl K; Willems P; Dougan ST
Am J Med Genet A; 2016 Jun; 170(6):1573-9. PubMed ID: 27028100
[TBL] [Abstract][Full Text] [Related]
17. Skeletal dysplasias of the fetus and infant: comprehensive review and our experience over a 10-year period.
Ježová M; Pavlovská D; Grochová I; Michenková A; Vlašín P
Cesk Patol; 2023; 59(2):68-79. PubMed ID: 37468326
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia.
Chen CP; Chern SR; Shih JC; Wang W; Yeh LF; Chang TY; Tzen CY
Prenat Diagn; 2001 Feb; 21(2):89-95. PubMed ID: 11241532
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of thanatophoric dysplasia and lethal osteogenesis imperfecta type II in Northern Ireland - a complete population study.
Donnelly DE; McConnell V; Paterson A; Morrison PJ
Ulster Med J; 2010 Sep; 79(3):114-8. PubMed ID: 22375084
[TBL] [Abstract][Full Text] [Related]
20. Rapid prenatal diagnosis of skeletal dysplasia using medical trio exome sequencing: Benefit for prenatal counseling and pregnancy management.
Han J; Yang YD; He Y; Liu WJ; Zhen L; Pan M; Yang X; Zhang VW; Liao C; Li DZ
Prenat Diagn; 2020 Apr; 40(5):577-584. PubMed ID: 31994750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
